Advanced Enzyme Technologies Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 8, 2026
- Posted by: Harsh Piplani
- Category: Results
Advanced Enzyme Technologies share price Rs 298.85 on 8 September 2026, up 0.34%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 38.59 crore. Q2 FY26 base a profit of Rs 44.73 crore.
Quick Answer
The Advanced Enzyme Technologies Q2 results date for FY27 is not confirmed, and Advanced Enzyme Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 194.81 crore in revenue and a profit of Rs 44.73 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Advanced Enzyme Technologies Q2 results FY27 announcement is the next scheduled earnings event for Advanced Enzyme Technologies Ltd., a producer of industrial enzymes and probiotics for human nutrition, animal feed, food processing and speciality industrial applications. The stock traded at Rs 298.85 on the NSE on 8 September 2026, up 0.34% from the previous close of Rs 297.85, about 28.7% below its 52-week high of Rs 419.00 and 18.6% above its 52-week low of Rs 251.95.
What makes the Advanced Enzyme Technologies Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 194.81 crore of revenue and a profit of Rs 44.73 crore, while the most recent quarter on record, Q1 FY27, produced Rs 202.81 crore and a profit of Rs 38.59 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Advanced Enzyme Technologies Q2 Results FY27 Date?
The Advanced Enzyme Technologies Q2 results date for FY27 is not confirmed. As of 8 September 2026, Advanced Enzyme Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Advanced Enzyme Technologies Q2 results date becomes public through that filing rather than through any advance announcement.
The Advanced Enzyme Technologies Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Advanced Enzyme Technologies.
Advanced Enzyme Technologies Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Advanced Enzyme Technologies Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Advanced Enzyme Technologies. The Advanced Enzyme Technologies Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is the margin slide. Operating margin fell to 33.72% in Q1 FY27 from 38.12% in the September 2025 quarter, the lowest of the last five, and that is why profit of Rs 38.59 crore came in below the Rs 44.73 crore base despite similar revenue.
The second is the export mix. A large share of enzyme sales goes to overseas nutrition and feed customers, so currency movement and shipment timing affect reported revenue independently of underlying demand.
The third is that revenue has been flat rather than growing. The top line has moved in a band between Rs 180.42 crore and Rs 210.60 crore across five quarters, so the September print is about margin repair rather than expansion.
Check Advanced Enzyme Technologies Ltd. Live Fundamentals on the Univest Screener
Advanced Enzyme Technologies Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Advanced Enzyme Technologies Ltd. reported revenue of Rs 202.81 crore in Q1 FY27, up 4.13% from Rs 194.76 crore in Q1 FY26, and a profit of Rs 38.59 crore at the net level, down 4.57% from Rs 40.44 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 3.70% over the March 2026 quarter figure of Rs 210.60 crore, and net profit was down 14.72% from Rs 45.25 crore in Q4 FY26. Operating margin stood at 33.72% in Q1 FY27 against 38.12% in the September 2025 quarter, which is the comparison the Advanced Enzyme Technologies Q2 results print will be read against.
Q2 FY26 Base: The Comparison Advanced Enzyme Technologies Q2 Results FY27 Must Beat
Advanced Enzyme Technologies Ltd. reported revenue of Rs 194.81 crore and a profit of Rs 44.73 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Advanced Enzyme Technologies Q2 results preview.
Net profit in that base quarter was above the Rs 38.59 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 194.81 crore sits below the Rs 202.81 crore of the June 2026 quarter, which frames how much sequential movement the Advanced Enzyme Technologies Q2 results print needs to show growth.
Advanced Enzyme Technologies Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 194.81 | 44.73 |
| Q3 FY26 (Dec 2025) | 180.42 | 43.18 |
| Q4 FY26 (Mar 2026) | 210.60 | 45.25 |
| Q1 FY27 (Jun 2026) | 202.81 | 38.59 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Advanced Enzyme Technologies Q2 results preview uses.
Revenue across those four quarters ranged from Rs 180.42 crore to Rs 210.60 crore, and net profit from Rs 38.59 crore to Rs 45.25 crore. That spread is the honest context for the Advanced Enzyme Technologies Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Advanced Enzyme Technologies Q2 Results FY27
The Advanced Enzyme Technologies Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Advanced Enzyme Technologies has already reported.
Human Nutrition and Probiotics Demand
The human nutrition segment carries the richest margins in the portfolio. Any shift in the balance between that business and lower-margin industrial or feed enzymes shows up directly in the operating margin line.
Regulatory Approvals in Export Markets
Enzyme and probiotic products require approvals in the markets they are sold into. Any registration gained or lost changes the addressable revenue for several quarters and is usually disclosed alongside results.
Undemanding Valuation With Low Debt
Advanced Enzyme Technologies trades at a price-to-earnings ratio of 19.39 against a sector average of 37.70, with a debt-to-equity ratio of 0.02 and a dividend yield of 1.80%. The stock sits below both its moving averages.
Advanced Enzyme Technologies Q2 Results FY27: Share Price and Valuation Going Into the Print
Advanced Enzyme Technologies share price today is Rs 298.85 on the NSE, up Rs 1.00 or 0.34% from the previous close of Rs 297.85 on 8 September 2026, ahead of the Advanced Enzyme Technologies Q2 results announcement.
| Metric | Value (8 September 2026) |
|---|---|
| NSE Symbol | ADVENZYMES |
| Current Market Price | Rs 298.85 |
| 52-Week High | Rs 419.00 |
| 52-Week Low | Rs 251.95 |
| Market Capitalisation | Rs 3,330 crore |
| PE Ratio | 19.39 |
| Sector PE | 37.70 |
| PB Ratio | 2.04 |
| EPS (TTM) | Rs 15.34 |
| Book Value per Share | Rs 145.72 |
| Debt to Equity | 0.02 |
| Return on Equity | 10.34% |
| 50-Day Moving Average | Rs 310.95 |
| 200-Day Moving Average | Rs 314.67 |
| RSI (14) | 38.80 |
The stock trades below both its 50-day average of Rs 310.95 and its 200-day average of Rs 314.67, with a 14-day RSI of 38.80. None of this is a view on where the shares go once the Advanced Enzyme Technologies Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Advanced Enzyme Technologies Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Advanced Enzyme Technologies Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Advanced Enzyme Technologies Q2 results print in proportion.
- Revenue against the Rs 194.81 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 44.73 crore in that same quarter
- Operating margin against 33.72% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Advanced Enzyme Technologies Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Advanced Enzyme Technologies Q2 Results FY27
The Advanced Enzyme Technologies Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Advanced Enzyme Technologies Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Advanced Enzyme Technologies Q2 results FY27 print faces a base of Rs 194.81 crore in revenue and a profit of Rs 44.73 crore, with the most recent quarter having delivered Rs 202.81 crore and a profit of Rs 38.59 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Advanced Enzyme Technologies, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Advanced Enzyme Technologies Q2 Results FY27
What is the Advanced Enzyme Technologies Q2 results date for FY27?
Ans. The Advanced Enzyme Technologies Q2 results date for FY27 is not confirmed. Advanced Enzyme Technologies Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Advanced Enzyme Technologies Q2 results 2026 cover?
Ans. The Advanced Enzyme Technologies Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Advanced Enzyme Technologies Ltd. reports revenue, operating profit and net profit for that period, and the Advanced Enzyme Technologies Q2 results filing also carries the notes to the accounts.
What were the Advanced Enzyme Technologies Q1 FY27 results?
Ans. Advanced Enzyme Technologies Ltd. reported revenue of Rs 202.81 crore in Q1 FY27 and a profit of Rs 38.59 crore at the net level. Revenue was up 4.13% versus Q1 FY26 and net profit was down 4.57% from Rs 40.44 crore in Q1 FY26.
What were Advanced Enzyme Technologies Q2 FY26 results in the September 2025 quarter?
Ans. Advanced Enzyme Technologies Ltd. reported revenue of Rs 194.81 crore and a profit of Rs 44.73 crore in Q2 FY26. Operating margin was 38.12%. Those figures form the base for the Advanced Enzyme Technologies Q2 results FY27 comparison.
What are the main Advanced Enzyme Technologies Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Advanced Enzyme Technologies Q2 results expectations centre on revenue against the Rs 194.81 crore base, net profit against a profit of Rs 44.73 crore, operating margin against 33.72% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Advanced Enzyme Technologies share price today ahead of the Q2 earnings?
Ans. Advanced Enzyme Technologies share price is Rs 298.85 on the NSE as of 8 September 2026, up 0.34% from Rs 297.85. The stock is about 28.7% below its 52-week high of Rs 419.00 and 18.6% above its 52-week low of Rs 251.95, at a market capitalisation of Rs 3,330 crore.
Is Advanced Enzyme Technologies a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Advanced Enzyme Technologies Ltd.. The stock trades at a price-to-book ratio of 2.04 with a return on equity of 10.34%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
